平安好医生（01833）今日盘中大涨15.37%，引发市场高度关注。这波强劲涨势主要源于里昂证券发布的最新研究报告，该报告大幅上调了平安好医生的目标价，并给予积极评级。
根据里昂的研究报告，平安好医生2025年上半年业绩表现亮眼。公司收入同比增长19.5%至25亿元人民币，调整后净利润更是同比大增136.8%至1.34亿元人民币。基于这一出色表现，里昂将平安好医生的目标价从10港元大幅上调至20港元，并重申"跑赢大市"评级。
里昂分析师认为，平安好医生是中国AI医疗和商业健康保险发展的主要受益者。报告指出，公司在医疗AI方面的进展和改善的盈利前景是推动股价上涨的主要因素。此外，里昂还上调了平安好医生2025年至2027年的收入和净利润预测。这份乐观的分析报告无疑提振了投资者信心，推动平安好医生股价今日大幅上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.